Yasser Joharji

Yasser Joharji serves as Chief Executive Officer of Nahdi Medical Company, a position he has held since 2014. He oversees 10,000 employees and manages a network of 1,207 pharmacies as of H1 2025. His company's NahdiCare division operates 12 polyclinics across nine Saudi cities, serving 1.4 million patients with 100 emergency beds. The group recorded $1.4 billion in revenues in the first six months of 2025 and held $1.7 billion in assets. Joharji is known for driving innovation, including the Ez-Pill service designed to support medication adherence aligned with Saudi Ministry of Health goals.

Joharji brings over 20 years of management experience. From 1998 to 2014, he spent 20 years at Unilever, where he held several vital positions including Brand Manager from 1998 to 2003 and General Manager of FMCG, personal care and household products from 2003 to 2008. From 2010 to 2014, he was General Manager at Unilever. Prior to Unilever, from 1993 to 1998, he served as Senior Brand Manager at Savola, one of the largest food companies in the Middle East.

Joharji holds a Bachelor's degree in Industrial Engineering from King Saud University, Saudi Arabia. He completed a Non-Executive Director Diploma in Board Director Programme from the Financial Times in 2018. He was recognized among Forbes Middle East's Top 10 Healthcare Leaders for 2025 and is featured in the 2026 rankings.

His leadership at Nahdi was selected as a case study by Harvard University's T.H. Chan School of Public Health, representing an integrated healthcare model taught to public health students. In May 2025, Nahdi partnered with Emerge to develop a 3 MWp rooftop solar system at its IMDAD distribution center.

What Yasser Joharji could bring to his CEO role at Nahdi Medical Company: Drawing on his extensive background in brand management, commercial growth strategy, and operational excellence across FMCG and healthcare sectors, Joharji has demonstrated capacity to scale enterprise operations from 20-year tenure at Unilever into a 10,000-person organization commanding $1.4 billion in revenue. His track record of driving innovation (Ez-Pill initiative), sustainability partnerships, and Harvard-recognized integrated healthcare models positions him to continue advancing Saudi Arabia's healthcare localization objectives while expanding Nahdi's regional and financial footprint.